Financial Statements

Ceylon Hospitals PLC

For the 2nd Quarter ended 30th September 2022

Financial Statements for the Six Months ended 30th September 2022

Consolidated Statement of Profit or Loss and Other Comprehensive Income

Accumulated Period of 6 Months

Group

Company

Group

Company

03 Months

03 Months

03 Months

03 Months

6 Months

6 Months

6 Months

6 Months

Ended

Ended

Ended

Ended

Ended

Ended

Ended

Ended

30/09/2022

30/09/2021

30/09/2022

30/09/2021

30/09/2022

30/09/2021

30/09/2022

30/09/2021

Rs. '000

Rs. '000

Rs. '000

Rs. '000

Rs. '000

Rs. '000

Rs. '000

Rs. '000

Revenue

1,935,334

2,100,407

1,090,224

1,430,105

3,579,817

3,980,538

1,996,441

2,689,770

Cost of Sales

(785,656)

(743,319)

(480,497)

(554,387)

(1,406,332)

(1,477,865)

(823,087)

(1,071,081)

Gross Profit

1,149,678

1,357,088

609,727

875,718

2,173,485

2,502,673

1,173,354

1,618,690

Other Operating Income

48,833

15,866

15,183

11,617

35,665

24,481

23,989

16,309

Administrative Expenses

(666,812)

(810,571)

(425,869)

(602,898)

(1,288,240)

(1,510,204)

(823,762)

(1,104,374)

Other Operating Expenses

(203,973)

(172,074)

(91,400)

(116,087)

(400,623)

(334,394)

(211,896)

(226,031)

Results from Operating Activities

327,726

390,309

107,641

168,351

520,287

682,556

161,685

304,594

Finance Cost

(14,743)

(16,596)

(11,876)

(16,480)

(30,326)

(40,468)

(24,554)

(39,247)

Finance Income

65,125

15,344

28,270

94,187

130,465

34,986

241,425

246,694

Gain on Bargain Purchase

-

-

-

-

-

12,002

-

-

Share of Profit of an Equity Accounted Investee

-

-

-

-

-

13,263

-

-

Profit before Taxation

378,108

389,056

124,035

246,058

620,426

702,338

378,556

512,041

-

Taxation

(88,329)

(95,014)

(11,731)

(46,889)

(123,643)

(178,556)

(26,876)

(88,655)

Net Profit after Taxation

289,779

294,042

112,304

199,169

496,783

523,782

351,680

423,386

Other Comprehensive Income

Items will not be reclassified to profit or loss

Net Change in Fair Value on Equity Investments at

FVOCI

3,922

8

(1,632)

8

2,042

64

28

64

Other Comprehensive Income for the Year

3,922

8

(1,632)

8

2,042

64

28

64

Total Comprehensive Income for the Year

293,701

294,050

110,672

199,177

498,825

523,846

351,708

423,450

Profit Attributable to:

Equity Holders of the Parent

251,147

244,288

112,304

199,169

435,446

437,979

351,680

423,386

Non-Controlling Interest

38,632

49,755

-

-

61,337

85,803

-

-

289,779

294,042

112,304

199,169

496,783

523,782

351,680

423,386

Total Comprehensive Income Attributable to: Equity Holders of the Parent Non-Controlling Interest

Earnings per Share - Basic

254,023

244,296

110,672

199,177

437,109

438,043

351,708

423,450

39,678

49,755

-

-

61,716

85,803

-

-

293,701

294,050

110,672

199,177

498,825

523,846

351,708

423,450

7.41

7.21

3.32

5.88

12.86

12.93

10.38

12.50

The above figures are provisional and subject to audit.

Ceylon Hospitals PLC

-1-

Financial Statements for the Six Months ended 30th September 2022

Consolidated Statement of Financial Position

GROUP

COMPANY

GROUP

COMPANY

Audited

Audited

Unaudited

Unaudited

Unaudited

Unaudited

As at

As at

As at

As at

As at

As at

31/03/2022

31/03/2022

30/09/2022

30/09/2021

30/09/2022

30/09/2021

Rs. '000

Rs. '000

Rs. '000

Rs. '000

Rs. '000

Rs. '000

ASSETS

Non-Current Assets

8,481,203

5,592,128

Property, Plant and Equipment

9,186,655

7,941,871

6,169,527

5,287,830

288,954

288,954

Right of Use Assets

286,690

204,321

284,060

204,321

-

1,457,821

Investments in Subsidiary

-

-

1,457,821

1,457,821

272,923

71,416

Other Financial Assets

298,841

332,728

74,114

67,532

890

-

Prepaid Rent

-

716

-

-

9,043,970

7,410,319

9,772,186

8,479,636

7,985,522

7,017,504

Current Assets

835,149

693,571

Inventories

951,788

593,760

750,526

503,038

306,454

214,955

Trade and Other Receivables

335,117

429,157

201,081

243,957

252,441

195,053

Prepayments

671,170

203,421

459,130

153,405

1,934

75,921

Amount Due from Related Parties

4,765

1,942

70,922

79,682

1,451,388

659,287

Other Financial Assets

1,018,082

939,384

397,222

131,638

13,278

13,259

Tax Refund Due

13,259

-

13,259

-

898,189

129,295

Cash and Cash Equivalents

501,920

693,099

195,754

124,132

3,758,833

1,981,341

3,496,101

2,860,763

2,087,894

1,235,852

12,802,803

9,391,660

Total Assets

13,268,287

11,340,399

10,073,416

8,253,356

EQUITY AND LIABILITIES

Equity Attributable to Equity holders of the parent

916,366

916,366

Stated Capital

916,366

916,366

916,366

916,366

2,691,662

2,134,544

Revaluation Reserve

2,691,662

2,691,662

2,134,544

2,134,544

65,868

600

Fair Value Reserve

67,531

68,500

628

192

3,873,950

2,695,436

Revenue Reserves

4,140,032

3,281,025

2,877,751

2,301,393

7,547,846

5,746,946

7,815,591

6,957,553

5,929,289

5,352,495

734,254

-

Non-Controlling Interests

759,599

691,378

-

-

8,282,100

5,746,946

Total Equity

8,575,190

7,648,931

5,929,289

5,352,495

Non-Current Liabilities

1,701,501

1,606,247

Interest Bearing Loans and Borrowings

1,882,377

881,800

1,808,464

831,341

-

31,470

Deferred Revenue

-

-

28,785

32,589

177,998

156,790

Retirement Benefit Obligations

182,741

247,654

159,371

221,519

707,793

452,599

Deferred Tax Liabilities

717,402

649,962

452,599

440,809

2,587,292

2,247,106

2,782,520

1,779,416

2,449,219

1,526,258

Current Liabilities

246,765

94,527

Bank Overdraft

188,526

233,260

154,964

126,197

306,060

248,830

Interest Bearing Loans and Borrowings

316,774

368,070

268,043

328,959

1,247,893

862,449

Trade and Other Payables

1,296,202

1,190,551

770,656

806,833

127,894

73,281

Taxation Payable

87,723

118,397

13,121

54,393

4,799

118,521

Amount Due to Related Parties

21,352

1,774

488,124

58,221

1,933,411

1,397,608

1,910,577

1,912,052

1,694,908

1,374,603

12,802,803

9,391,660

Total Equity and Liabilities

13,268,287

11,340,399

10,073,416

8,253,356

The above figures are provisional and subject to audit.

Sgd

Thusitha Rubasinghe

Chief Financial Officer

The Board of Directors is responsible for the preparation and presentation of these Financial Statements.

Signed for and on behalf of the Board by,

Sgd

Sgd

A E Tudawe

U D Tudawe

Chairman

Director

10th November 2022

Ceylon Hospitals PLC

- 2 -

Financial Statements for the Six Months ended 30th September 2022

CEYLON HOSPITALS PLC

STATEMENT OF CHANGES IN EQUITY

Group

Stated

Revaluation

Fair Value

Revenue

Total

Non-Controlling

Total

Capital

Reserve

Reserve

Reserves

Interests

Rs. '000

Rs. '000

Rs. '000

Rs. '000

Rs. '000

Rs. '000

Rs. '000

Balance as at 31st March 2021

916,366

2,691,662

68,436

2,951,439

6,627,903

592,626

7,220,529

Net Profit for the Year

-

-

-

982,324

982,324

127,202

1,109,526

Other Comprehensive Income

Actuarial Gain on Gratuity Valuation

-

-

-

55,965

55,965

300

56,265

Deferred Tax on Gratuity Valuation

-

-

-

(6,342)

(6,342)

332

(6,010)

Prior Year Adjustments - Inventory Written-off

-

-

-

(989)

(989)

(230)

(1,219)

Net Change in Fair Value on Equity Investments at FVTOCI

-

-

(2,568)

-

(2,568)

217

(2,351)

Share Buyback

-

-

-

(54)

(54)

-

(54)

Total Comprehensive Income for the Year

-

-

(2,568)

1,030,904

1,028,335

127,822

1,156,158

Transactions with Owners in their capacity as Owners

Non-Controlling Interest on Acquisition of Subsidiary

-

-

-

-

-

127,301

127,301

Dividend Paid - Ordinary Shares

-

-

-

(108,393)

(108,393)

(113,495)

(221,888)

-

-

-

(108,393)

(108,393)

13,806

(94,587)

Balance as at 31st March 2022

916,366

2,691,662

65,868

3,873,950

7,547,845

734,254

8,282,100

Net Profit for the Six months ended 30 September 2022

-

-

-

435,446

435,446

61,337

496,783

Other Comprehensive Income

Net Profit on equity instruments designnated at fair-

-Value through other comprehensive income

-

-

1,663

-

1,663

379

2,042

Total Comprehensive Income for the Six Months Ended 30 September 2022

-

-

1,663

435,446

437,109

61,716

498,825

Transactions with Owners in their capacity as Owners

Shares issued at Rights Issue by subsidiary

-

-

-

-

-

5,860

5,860

Dividend Paid - Ordinary Shares

-

-

-

(169,364)

(169,364)

(42,231)

(211,595)

-

-

-

(169,364)

(169,364)

(36,371)

(205,735)

Balance as at 30th September 2022

916,366

2,691,662

67,531

4,140,032

7,815,590

759,599

8,575,190

Company

Stated

Revaluation

Fair Value

Revenue

Total

Capital

Reserve

Reserve

Reserves

Rs. '000

Rs. '000

Rs. '000

Rs. '000

Rs. '000

Balance as at 31st March 2021

916,366

2,134,544

128

1,986,400

5,037,438

Net Profit for the Year

-

-

-

770,550

770,550

Other Comprehensive Income

Deferred Tax Effect on Revaluation Gain

-

-

-

-

-

Actuarial Gain on Gratuity Valuation

-

-

-

54,510

54,510

Deferred Tax Effect on Gratuity Valuation

-

-

-

(7,631)

(7,631)

Net Change in Fair Value on Equity Investments at FVTOCI

-

-

472

-

472

Total Comprehensive Income for the Year

-

-

472

817,429

817,901

Transactions with Owners in their capacity as Owners

Dividend Paid - Ordinary Shares

-

-

-

(108,393)

(108,393)

-

-

-

(108,393)

(108,393)

Balance as at 31st March 2022

916,366

2,134,544

600

2,695,436

5,746,946

Net Profit for the Six months ended 30 September 2022

-

-

-

351,680

351,680

Other Comprehensive Income

Net Profit on equity instruments designnated at fair-

-

-Value through other comprehensive income

-

-

28

-

28

Total Comprehensive Income for the Six Months ended 30 September 2022

-

-

28

351,680

351,708

Transactions with Owners in their capacity as Owners

Dividend Paid - Ordinary Shares

-

-

-

(169,364)

(169,364)

-

-

-

(169,364)

(169,364)

Balance as at 30th September 2022

916,366

2,134,544

628

2,877,751

5,929,289

- 3-

Financial Statements for the Six Months ended 30th September 2022

Consolidated Statement of Changes in Equity

For the period ended 30th September 2021

Group

Stated

Revaluation

Fair Value

Revenue

Total

Non Controlling

Total

Capital

Reserve

Reserve

Reserves

Interests

Rs. '000

Rs. '000

Rs. '000

Rs. '000

Rs. '000

Rs. '000

Rs. '000

Balance as at 31st March 2020

916,366

2,483,785

65,922

2,439,753

5,905,826

587,760

6,493,586

Net Profit for the Year

-

-

-

560,349

560,349

39,910

600,259

Other Comprehensive Income

Deferred Tax Effect on Revaluation Gain

-

207,877

-

-

207,877

752

208,629

Actuarial Gain on Gratuity valuation

-

-

-

32,865

32,865

370

33,235

Deferred Tax Effect on Gratuity valuation

-

-

-

(7,007)

(7,007)

(610)

(7,617)

Net Change in Fair Value on Equity Investments at FVTOCI

-

-

2,514

-

2,514

554

3,068

Total Comprehensive Income for the Year

-

207,877

2,514

586,206

796,597

40,975

837,572

Transactions with Owners in their capacity as Owners

Share of additional capital attributable to NCI

-

-

-

-

-

1,750

1,750

Dividend Paid - Ordinary Shares

-

-

-

(74,520)

(74,520)

(37,859)

(112,379)

-

-

-

(74,520)

(74,520)

(36,109)

(110,629)

Balance as at 31st March 2021

916,366

2,691,662

68,436

2,951,439

6,627,903

592,626

7,220,530

Net Profit for the six months ended 30 September 2021

-

-

-

437,979

437,979

85,803

523,782

Other Comprehensive Income

Net Change in Fair Value on Equity Investments at FVTOCI

-

-

64

-

64

-

64

Total Comprehensive Income for the Six months ended 30 September 2021

-

-

64

437,979

438,043

85,803

523,846

Transactions with Owners in their capacity as Owners

Non-Controlling Interest on Acquisition of Subsidiay

-

-

-

-

-

126,444

126,444

Dividend Paid - Ordinary Shares

-

-

-

(108,393)

(108,393)

(113,496)

(221,889)

-

-

-

(108,393)

(108,393)

12,948

(95,444)

Balance as at 30th September 2021

916,366

2,691,662

68,500

3,281,025

6,957,553

691,378

7,648,931

Company

Stated

Revaluation

Fair Value

Revenue

Total

Capital

Reserve

Reserve

Reserves

Rs. '000

Rs. '000

Rs. '000

Rs. '000

Rs. '000

Balance as at 31st March 2020

916,366

1,931,063

-

1,588,064

4,435,493

Net Profit for the Year

-

-

-

446,118

446,118

Other Comprehensive Income

Deferred Tax Effect on Revaluation Gain

-

203,481

-

-

203,481

Actuarial Gain on Gratuity valuation

-

-

-

31,090

31,090

Deferred Tax Effect on Gratuity valuation

-

-

-

(4,353)

(4,353)

Net Change in Fair Value on Equity Investments at FVTOCI

-

-

128

-

128

Total Comprehensive Income for the Year

-

203,481

128

472,855

676,464

Transactions with Owners in their capacity as Owners

Dividend Paid - Ordinary Shares

-

-

-

(74,520)

(74,520)

-

-

-

(74,520)

(74,520)

Balance as at 31st March 2021

916,366

2,134,544

128

1,986,400

5,037,438

Net Profit for the six months ended 30 September 2021

-

-

-

423,386

423,386

Other Comprehensive Income

Net Change in Fair Value on Equity Investments at FVTOCI

-

-

64

-

64

Total Comprehensive Income for the Six months ended 30 September 2021

-

-

64

423,386

423,450

Transactions with Owners in their capacity as Owners

Dividend Paid - Ordinary Shares

-

-

-

(108,393)

(108,393)

-

-

-

(108,393)

(108,393)

Balance as at 30th September 2021

916,366

2,134,544

192

2,301,393

5,352,495

Ceylon Hospitals PLC

- 4 -

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Ceylon Hospitals plc published this content on 14 November 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 November 2022 03:31:03 UTC.